PHASE-II TRIAL OF TRIGLYCIDYLURAZOL (TGU) IN ADVANCED MALIGNANT-MELANOMA

被引:0
|
作者
GUNDERSEN, S
ABELE, R
CAVALLI, F
CLAVEL, M
DODION, P
RENARD, G
VANGLABBEKE, M
机构
[1] HOP CANTONAL,CH-1205 GENEVA,SWITZERLAND
[2] OSPED SAN GIOVANNI,SERV ONCOL,CH-6500 BELLINZNA,SWITZERLAND
[3] CTR LEON BERARD,F-69373 LYON 2,FRANCE
[4] INST JULES BORDET,B-1000 BRUSSELS,BELGIUM
[5] EORTC DATA CTR,B-1000 BRUSSELS,BELGIUM
来源
关键词
D O I
10.1016/0277-5379(87)90022-8
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:251 / 252
页数:2
相关论文
共 50 条
  • [41] PHASE-II STUDY OF TAUROMUSTINE IN DISSEMINATED MALIGNANT-MELANOMA
    NOLTE, H
    GJEDDE, SB
    LINDEGAARDMADSEN, E
    BERGH, J
    BLOMQUIST, E
    MOURIDSEN, HT
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (04): : 655 - 657
  • [42] PHASE-II STUDY OF MITOMYCIN IN DISSEMINATED MALIGNANT-MELANOMA
    CREAGAN, ET
    EDMONSON, JH
    AHMANN, DL
    CHANG, M
    CANCER TREATMENT REPORTS, 1985, 69 (12): : 1451 - 1452
  • [43] PHASE-II STUDY OF VINDESINE IN METASTATIC MALIGNANT-MELANOMA
    ARSENEAU, JC
    MELLETTE, SJ
    KUPERMINC, M
    WOLTER, J
    CANCER TREATMENT REPORTS, 1981, 65 (3-4): : 355 - 356
  • [44] A PHASE-II INVESTIGATION OF PENTOSTATIN IN METASTATIC MALIGNANT-MELANOMA
    GREVER, M
    BRAGER, P
    KRAUT, E
    METZ, E
    INVESTIGATIONAL NEW DRUGS, 1992, 10 (04) : 345 - 346
  • [45] PHASE-II STUDY OF TAUROMUSTINE IN DISSEMINATED MALIGNANT-MELANOMA
    GJEDDE, SB
    MOURIDSEN, HT
    LMADSEN, E
    JENSEN, NV
    BLOMQUIST, E
    BERGH, J
    SODERBERG, M
    WAHLBY, S
    EUROPEAN JOURNAL OF CANCER, 1994, 30A (04) : 566 - 566
  • [46] PHASE-II STUDY OF ILMOFOSINE IN PATIENTS WITH MALIGNANT-MELANOMA
    HEIM, ME
    KLEEBERG, UR
    WINKELMANN, M
    BECHER, R
    MANEGOLD, C
    QUEISSER, U
    RIECHE, K
    KLEE, M
    EDLER, L
    ONKOLOGIE, 1992, 15 (06): : 465 - 469
  • [47] A PHASE-II STUDY OF TAXOL IN PATIENTS WITH MALIGNANT-MELANOMA
    EINZIG, AI
    HOCHSTER, H
    WIERNIK, PH
    TRUMP, DL
    DUTCHER, JP
    GAROWSKI, E
    SASLOFF, J
    SMITH, TJ
    INVESTIGATIONAL NEW DRUGS, 1991, 9 (01) : 59 - 64
  • [48] PHASE-II EVALUATION OF CHLOROZOTOCIN IN PATIENTS WITH MALIGNANT-MELANOMA
    HOUGHTON, AN
    CAMACHO, FJ
    GRALLA, RJ
    WITTES, R
    CANCER TREATMENT REPORTS, 1981, 65 (7-8): : 705 - 706
  • [49] PHASE-II TRIAL OF RECOMBINANT INTERFERON-ALPHA WITH BCNU, CISPLATIN, DTIC AND TAMOXIFEN IN ADVANCED MALIGNANT-MELANOMA
    FEUN, LG
    SAVARAJ, N
    MOFFAT, F
    ROBINSON, D
    LIEBMANN, A
    HURLEY, J
    RAUB, WA
    RICHMAN, SP
    MELANOMA RESEARCH, 1995, 5 (04) : 273 - 276
  • [50] PHASE-II TRIAL OF PCNU IN ADVANCED MALIGNANT-MELANOMA - AN EASTERN COOPERATIVE ONCOLOGY GROUP PILOT-STUDY
    EARHART, RH
    MUGGIA, FM
    GOLOMB, FM
    INVESTIGATIONAL NEW DRUGS, 1985, 3 (03) : 297 - 301